Literature DB >> 33197007

Advantages and Limitations of Cre Mouse Lines Used in Skeletal Research.

Florent Elefteriou1,2, Greig Couasnay3.   

Abstract

The Cre-LoxP technology permits gene ablation in specific cell lineages, at chosen differentiation stages of this lineage and in an inducible manner. It has allowed tremendous advances in our understanding of skeleton biology and related pathophysiological mechanisms, through the generation of loss/gain of function or cell tracing experiments based on the creation of an expanding toolbox of transgenic mice expressing the Cre recombinase in skeletal stem cells, chondrocytes, osteoblasts, or osteoclasts. In this chapter, we provide an overview of the different Cre-LoxP systems and Cre mouse lines used in the bone field, we discuss their advantages, limitations, and we outline best practices to interpret results obtained from the use of Cre mice.

Entities:  

Keywords:  Chondrocytes; Cre-recombinase; Floxed gene; Mouse model; Off target; Osteoblasts; Osteoclasts; Osteocytes; Specificity; Transgenic mice

Mesh:

Substances:

Year:  2021        PMID: 33197007     DOI: 10.1007/978-1-0716-1028-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  The Osteocyte Transcriptome: Discovering Messages Buried Within Bone.

Authors:  Natalie Ky Wee; Natalie A Sims; Roy Morello
Journal:  Curr Osteoporos Rep       Date:  2021-11-10       Impact factor: 5.096

2.  Conditional loss of IKKα in Osterix + cells has no effect on bone but leads to age-related loss of peripheral fat.

Authors:  Jennifer L Davis; Nitin Kumar Pokhrel; Linda Cox; Nidhi Rohatgi; Roberta Faccio; Deborah J Veis
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

3.  Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice.

Authors:  Zamzam Awida; Sahar Hiram-Bab; Almog Bachar; Hussam Saed; Dan Zyc; Anton Gorodov; Nathalie Ben-Califa; Sewar Omari; Jana Omar; Liana Younis; Jennifer Ana Iden; Liad Graniewitz Visacovsky; Ida Gluzman; Tamar Liron; Bitya Raphael-Mizrahi; Albert Kolomansky; Martina Rauner; Ben Wielockx; Yankel Gabet; Drorit Neumann
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.